Article
Molecular Imaging of σ1 Receptors In Vivo: Current Status and Perspectives
1 Nov 2013
Abstract excerpt
It is widely accepted that sigma ( σ) receptors represent a new and different avenue in the possible pharmacological treatment of cancer and several brain-related disorders. Of the two different σ receptor types the σ1 receptors are assumed to be of major impact for brain diseases. Molecular imaging of brain σ1 receptors with positron emission tomography (PET) or single photon emission computed tomography (SPECT)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
